Director – Biology/Immunobiology

Location:  Moscow, Russia

Reports to:  Vice President R&D

Duties and Responsibilities:

The successful candidate will contribute leadership, technical expertise and intellectual creativity towards the development of targeted particle-based immunomodulatory agents, and will be proficient in both in vitro and in vivo techniques to measure and modify adaptive immune responses. As an early member of the Selecta Russia team, this individual will have the opportunity to play a central role in establishing our company's immunobiological capabilities, and will provide development support for internal projects and external collaborations. Because the company's therapeutic strategy integrates polymer chemistry, particle delivery technology and a number of immunological modalities, the candidate will be facile at collaborating across multiple technical disciplines.  Specific skill sets required include:

• In vivo assays to induce and/or modulate antigen-specific cellular and humoral immune responses in mammals
• In vitro assays that measure antigen-specific cellular and humoral immunity
• Bacterial and viral infectious disease models and/or cancer models
• Development of immunological-based assays (i.e. ELISAs, EliSPOT, multi-color flow cytometry, Immunohistochemistry, fluorescence microscopy)
• In vitro cell binding and pharmacological assays
• Basic molecular biology knowledge
• Experience with biotherapeutics, such as monoclonal antibodies

Transfer of knowhow from Selecta Biosciences (Boston, MA, USA) as well independent development at Selecta Russia will be part of the position. The successful candidate will be a highly motivated team player with a commitment to quality, and attention to detail, strong problem solving skills, excellent verbal, and written communication skills in English and Russian as well as the ability to work productively with minimal supervision. Travel to the United States for training and other research related functions at Selecta's USA facilities will also be part of the role.

Education Requirements: Ph.D. in immunology, immunobiology, microbiology or vaccinology

Experience: Substantial hands-on experience in immunology, molecular biology, cell biology, and/or biochemistry with post-doctoral training and 8 years of industry experience in a biotechnology or pharmaceutical company setting.  Experience in filing regulatory applications is desirable.

About Selecta:

Selecta Biosciences, Inc. is a biopharmaceutical company developing an entirely new class of targeted vaccines that induces an antigen-specific immune activation or antigen-specific immune tolerance for therapeutic and prophylactic applications. Selecta's proprietary Synthetic Vaccine Particle (SVP™) platform creates a new paradigm in vaccine development, enabling completely new therapeutic applications while offering the potential of improved efficacy and safety profiles. Selecta's fully synthetic engineering of novel vaccines offers a number of compelling benefits, including flexible modular vaccine design and accelerated development timelines using robust manufacturing processes.  Selecta's SVP™ platform technology is flexible to enable diverse vaccines and the company has created antigen-specific targeted Synthetic Vaccine Particles (tSVP™) and antigen-specific targeted tolerogenic Synthetic Vaccine Particles (t²SVP™).

Selecta was founded based on the advanced nanoparticle technology from the laboratories of two leaders in the field of targeted nanotechnology, Professor Robert Langer, Institute Professor of the Massachusetts Institute of Technology (MIT) and Professor Omid Farokhzad of Harvard Medical School as well as immunology research of Professor Ulrich von Andrian at Harvard Medical School.  Selecta Biosciences is based in Watertown, Massachusetts, USA.  For more information, please visit www.selectabio.com.

About Selecta Russia:

Selecta Russia is a wholly-owned subsidiary of Selecta Biosciences, Inc.

The company mission is to build a robust pipeline of Synthetic Vaccine Particles (SVP™) vaccines for the global marketplace. Our activities in Russia support Selecta Biosciences' goals of expanding its vaccine portfolio and accelerating its clinical development, while recognizing the specific requirements of Russian patients. Selecta Russia R&D programs are developed in close coordination with Selecta in Boston and include prophylactic and therapeutic vaccines in a wide range of therapeutic areas including infectious diseases, cancer, and addiction.

Please email your Resume/CV in English and Russian language to careers@selectabio.com.

NO PHONE CALLS OR AGENCIES PLEASE. 

Selecta Biosciences, Inc. is an equal opportunity employer offering a competitive salary and benefits package.

Please refer to Job Code RUS-BIO1 when corresponding about this position.